{"id":8739,"date":"2024-06-28T10:21:56","date_gmt":"2024-06-28T02:21:56","guid":{"rendered":"https:\/\/clinicalvalue.com\/?p=8739"},"modified":"2024-06-28T10:21:56","modified_gmt":"2024-06-28T02:21:56","slug":"advancements-challenges-and-strategies-surrounding-hcc-surveillance","status":"publish","type":"post","link":"https:\/\/clinicalvalue.com\/en-au\/advancements-challenges-and-strategies-surrounding-hcc-surveillance\/","title":{"rendered":"Advancements, challenges, and strategies surrounding HCC surveillance"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text]Roche Diagnostics Australia held an Independent Medical Education meeting exploring the approach to Hepatocellular Carcinoma (HCC) surveillance in Australia in Melbourne.<\/p>\n<p>The event aimed to provide valuable insights into the latest advancements, challenges, and strategies surrounding HCC surveillance.<\/p>\n<p>The meeting featured presentations from esteemed experts including A\/Prof Simone Strasser, A\/Prof Jessica Howell, Dr Manfred Spanger and Dr Ericka Flores and a panel discussion involving real-world case studies.<\/p>\n<p>When asked on the key takeaways for the meeting A Prof Simone Strasser commented \u201c\u2026an understanding of the changing epidemiology of liver disease and liver cancer in Australia, and that we are going to have to enable the healthcare system and primary care to apply surveillance to<br \/>\nmore and more people and that\u2019s not going to be ultrasound based surveillance because we don\u2019t have enough ultrasound practices and technicians in Australia to be able to apply to the whole community at risk and so we are going to need to have blood biomarkers that are applicable to that community.\u201d[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_video link=&#8221;https:\/\/vimeo.com\/970199728\/0e879e4fdd&#8221; title=&#8221;Watch the full video&#8221;][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]Roche Diagnostics Australia held an Independent Medical Education meeting exploring the approach to Hepatocellular Carcinoma (HCC) surveillance in Australia in Melbourne. The event aimed to provide valuable insights into the latest advancements, challenges, and strategies surrounding HCC surveillance. The meeting featured presentations from esteemed experts including A\/Prof Simone Strasser, A\/Prof Jessica Howell, Dr Manfred Spanger and Dr Ericka Flores and&#8230;<\/p>\n","protected":false},"author":19,"featured_media":8743,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1295],"tags":[1301,1322],"cancer-type":[],"country":[1268],"class_list":["post-8739","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-webinars-and-symposiums-en-au","tag-hcc-en-au","tag-hcc-surveillance-en-au","country-au"],"jetpack_featured_media_url":"https:\/\/clinicalvalue.com\/app\/uploads\/2024\/06\/HCC-Full-Video.png","_links":{"self":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts\/8739"}],"collection":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/comments?post=8739"}],"version-history":[{"count":4,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts\/8739\/revisions"}],"predecessor-version":[{"id":8745,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/posts\/8739\/revisions\/8745"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/media\/8743"}],"wp:attachment":[{"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/media?parent=8739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/categories?post=8739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/tags?post=8739"},{"taxonomy":"cancer-type","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/cancer-type?post=8739"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/clinicalvalue.com\/en-au\/wp-json\/wp\/v2\/country?post=8739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}